Company Filing History:
1 out of 20 
1 out of 1 Years Active: 2021
Title: Hirobumi Shibata: Innovator in Biocompatible Adhesives
Introduction
Hirobumi Shibata, based in Tokyo, Japan, is a prominent inventor recognized for his contributions to the field of biocompatible adhesives. With a patent to his name, he has made significant advancements in the realm of hard tissue bonding, enhancing medical practices and patient outcomes.
Latest Patents
Hirobumi Shibata's notable patent revolves around an adhesive for hard tissue bonding, which is crucial for various medical applications. This innovative adhesive exhibits sufficient pot life and remarkable biocompatibility, enabling it to be gradually replaced by bone over time. His patent includes a comprehensive adhesive kit that houses a liquid agent containing a cyanoacrylate monomer and a powdery agent made up of beta-tricalcium phosphate or hydroxyapatite. Additionally, he developed bone cement that combines a cyanoacrylate polymer with beta-tricalcium phosphate or hydroxyapatite, also known for its excellent biocompatibility.
Career Highlights
Hirobumi Shibata's career includes fruitful tenures at the Chiba Institute of Technology and Fukuyamaika Corporation. His work at these institutions has been instrumental in his development of innovative adhesive technologies, specifically targeting the challenges associated with hard tissue bonding in medical procedures.
Collaborations
Throughout his career, Hirobumi Shibata has collaborated with esteemed coworkers such as Kazuaki Hashimoto and Syuhei Aida. These partnerships have fostered an environment of innovation and supported the advancement of new ideas and technologies within the medical field.
Conclusion
Hirobumi Shibata stands out as a significant figure in the development of biocompatible adhesives. His unique combination of expertise and innovative spirit leads to advancements that have the potential to transform hard tissue bonding practices in the medical community. His contributions not only demonstrate the power of innovation in healthcare but also pave the way for future research and development in biocompatible materials.